The phrase "agents incurred" is correct and usable in written English.
It can be used in contexts where you are discussing costs, expenses, or liabilities that agents have accumulated or taken on.
Example: "The agents incurred significant expenses during the investigation, which will need to be reimbursed."
Alternatives: "agents accumulated" or "agents faced".
First, a novel protocol that structures the interaction by capturing the commitments that agents incur when using rewards.
Specifically, it chooses the awards vector at which all agents incur equal losses, subject to no one receiving a negative amount: for each ((E,c in mathfrak {B}) and each (iin N,) begin{aligned} textit{CEL}_{i}(E,c equiv max { 0,c_{i}-mu }, end{aligned}where (mu ) is chosen so that (sum _{iin N}max { 0,c_{i}-mu } =E).
Biological agents incur higher direct treatment costs.
In synthesis, we can split the cost of an enterprise into two parts: one part is the family agent cost incurred by family involvement, whereas the other is the ordinary agent cost not caused by family involvement.
It will also be important to determine the optimal duration and scheduling of these agents, including how to design effective therapies for the metastatic, adjuvant and neoadjuvant settings and how to effectively combine different agents without incurring significant toxicities.
The more complex the deliberative calculation, the more costs the agent incurs.
The maximal level on awards implies a limit on the losses the agent incurs.
Even for Batson, the question of whether the agent will act on his or her altruistic motivations depends ultimately on how strong they are and what costs the agent would incur in helping another person.
Generally, there is no need for the principal to consider corporate income taxation in the design of compensation contracts as long as it does not impact the agent's expected utility or the costs incurred by the agent.
In order to overcome both the dose-limiting side effects of conventional chemotherapeutic agents and the therapeutic failure incurred from multidrug resistant (MDR) tumor cells, we explored the possibility of loading doxorubicin onto biocompatible, lipid-modified dextran-based polymeric nanoparticles and evaluated the efficacy.
